The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Open accessAbstract
Background: The human heart primarily metabolizes fatty acids, and this decreases as alternative fuel use rises in heart failure with reduced ejection fraction (HFrEF). Patients with severe obesity and diabetes are thought to have increased myocardial fatty acid metabolism, but whether this is found in those who also have heart failure with preserved ejection fraction (HFpEF) is unknown. Methods: Plasma and endomyocardial biopsies were obtained from HFpEF (n=38), HFrEF (n=30), and nonfailing donor controls (n=20). Quantitative targeted metabolomics measured organic acids, amino acids, and acylcarnitines in myocardium (72 metabolites) and plasma (69 metabolites). The results were integrated with reported RNA sequencing data. Metabolomics were analyzed using agnostic clustering tools, Kruskal-Wallis test with Dunn test, and machine learning. Results: Agnostic clustering of myocardial but not plasma metabolites separated disease groups. Despite more obesity and diabetes in HFpEF versus HFrEF (body mass index, 39.8 kg/m 2 versus 26.1 kg/m 2 ; diabetes, 70% versus 30%; both P <0.0001), medium- and long-chain acylcarnitines (mostly metabolites of fatty acid oxidation) were markedly lower in myocardium from both heart failure groups versus control. In contrast, plasma levels were no different or higher than control. Gene expression linked to fatty acid metabolism was generally lower in HFpEF versus control. Myocardial pyruvate was higher in HFpEF whereas the tricarboxylic acid cycle intermediates succinate and fumarate were lower, as were several genes controlling glucose metabolism. Non–branched-chain and branched-chain amino acids (BCAA) were highest in HFpEF myocardium, yet downstream BCAA metabolites and genes controlling BCAA metabolism were lower. Ketone levels were higher in myocardium and plasma of patients with HFrEF but not HFpEF. HFpEF metabolomic-derived subgroups were differentiated by only a few differences in BCAA metabolites. Conclusions: Despite marked obesity and diabetes, HFpEF myocardium exhibited lower fatty acid metabolites compared with HFrEF. Ketones and metabolites of the tricarboxylic acid cycle and BCAA were also lower in HFpEF, suggesting insufficient use of alternative fuels. These differences were not detectable in plasma and challenge conventional views of myocardial fuel use in HFpEF with marked diabetes and obesity and suggest substantial fuel inflexibility in this syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
MissForest—Non-parametric missing value imputation for mixed-type data
Stekhoven, D. J., & Bühlmann, P. (2012) · Bioinformatics · doi:10.1093/bioinformatics/btr597 · Cited by 6,156
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Global burden of heart failure: a comprehensive and updated review of epidemiology
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac013 · Cited by 3,315
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183
Pieske, B., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M., Guazzi, M., Lam, C. S. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz641 · Cited by 1,855
A flexible R package for nonnegative matrix factorization
Gaujoux, R., & Seoighe, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-367 · Cited by 1,547
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation
Jopling, C., Sleep, E., Raya, M., Martí, M., Raya, A., & Belmonte, J. C. I. (2010) · Nature · doi:10.1038/nature08899 · Cited by 1,333
Sestrin2 is a leucine sensor for the mTORC1 pathway
Wolfson, R. L., Chantranupong, L., Saxton, R. A., Shen, K., Scaria, S. M., Cantor, J. R., & Sabatini, D. M. (2016) · Science · doi:10.1126/science.aab2674 · Cited by 1,306
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199
Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T. R., & Muscelli, E. (2016) · Diabetes · doi:10.2337/db15-1356 · Cited by 712
The Failing Heart Relies on Ketone Bodies as a Fuel
Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., Koves, T., Gardell, S. J., Krüger, M., Hoppel, C. L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017355 · Cited by 707
Self-citationZile, M. R., Baicu, C. F., S. Ikonomidis, J., Stroud, R. E., Nietert, P. J., Bradshaw, A. D., Slater, R., Palmer, B. M., Van Buren, P., Meyer, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013215 · Cited by 681
Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G. S., & DeLany, J. P. (2010) · Obesity · doi:10.1038/oby.2009.510 · Cited by 653
Bedi, K. C., Snyder, N. W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A. J., Wang, L. L., Javaheri, A., Blair, I. A., Margulies, K. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017545 · Cited by 650
Self-citationWestermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.931451 · Cited by 644
Nassif, M. E., Windsor, S. L., Borlaug, B. A., Kitzman, D. W., Shah, S. J., Tang, F., Khariton, Y., Malik, A. O., Khumri, T., Umpierrez, G., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01536-x · Cited by 618
Self-citationComprehensive quantification of fuel use by the failing and nonfailing human heart
Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020) · Science · doi:10.1126/science.abc8861 · Cited by 580
Self-citationCatabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure
Sun, H., Olson, K. C., Gao, C., Prosdocimo, D. A., Zhou, M., Wang, Z., Jeyaraj, D., Youn, J.-Y., Ren, S., Liu, Y., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020226 · Cited by 538
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão-Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 525
Nielsen, R., Møller, N., Gormsen, L. C., Tolbod, L. P., Hansson, N. H., Sorensen, J., Harms, H. J., Frøkiær, J., Eiskjaer, H., Jespersen, N. R., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036459 · Cited by 518
Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002179 · Cited by 417
A molecular model of human branched-chain amino acid metabolism
Suryawan, A., Hawes, J. W., Harris, R. A., Shimomura, Y., Jenkins, A. E., & Hutson, S. M. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.1.72 · Cited by 412
Li, T., Zhang, Z., Kolwicz, S. C., Abell, L., Roe, N. D., Kim, M., Zhou, B., Cao, Y., Ritterhoff, J., Gu, H., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.005 · Cited by 401
Self-citationPieske, B., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M., Guazzi, M., Lam, C. S. P., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1741 · Cited by 394
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense
Horton, J. L., Davidson, M. T., Kurishima, C., Vega, R. B., Powers, J. C., Matsuura, T. R., Petucci, C., Lewandowski, E. D., Crawford, P. A., Muoio, D. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124079 · Cited by 364
Self-citationL-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase
Sener, A., & Malaisse, W. J. (1980) · Nature · doi:10.1038/288187a0 · Cited by 352
Lipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 352
Acylcarnitines activate proinflammatory signaling pathways
Rutkowsky, J. M., Knotts, T. A., Ono-Moore, K. D., McCoin, C. S., Huang, S., Schneider, D., Singh, S., Adams, S. H., & Hwang, D. H. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00656.2013 · Cited by 332
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Knutsdottir, H., Luo, X., Bedi, K., Margulies, K. B., Haldar, S. M., Stolina, M., Yin, J., Khakoo, A. Y., Vaishnav, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050498 · Cited by 291
Self-citationLai, L., Leone, T. C., Keller, M. P., Martin, O. J., Broman, A. T., Nigro, J., Kapoor, K., Koves, T. R., Stevens, R., Ilkayeva, O. R., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001469 · Cited by 291
Self-citationCardiomyopathy in obesity, insulin resistance and diabetes
Nakamura, M., & Sadoshima, J. (2020) · The Journal of Physiology · doi:10.1113/jp276747 · Cited by 286
Hunter, W. G., Kelly, J. P., McGarrah, R. W., Khouri, M. G., Craig, D., Haynes, C., Ilkayeva, O., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003190 · Cited by 271
Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus
Herrero, P., Peterson, L. R., McGill, J. B., Matthew, S., Lesniak, D., Dence, C., & Gropler, R. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.030 · Cited by 265
Mitochondrial substrate utilization regulates cardiomyocyte cell-cycle progression
Cardoso, A. C., Lam, N. T., Savla, J. J., Nakada, Y., Pereira, A. H. M., Elnwasany, A., Menendez-Montes, I., Ensley, E. L., Bezan Petric, U., Sharma, G., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0169-x · Cited by 243
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
Zordoky, B. N., Sung, M. M., Ezekowitz, J., Mandal, R., Han, B., Bjorndahl, T. C., Bouatra, S., Anderson, T., Oudit, G. Y., Wishart, D. S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124844 · Cited by 216
Kitzman, D. W., & Shah, S. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.019 · Cited by 194
Boosting NAD+ with a small molecule that activates NAMPT
Gardell, S. J., Hopf, M., Khan, A., Dispagna, M., Hampton Sessions, E., Falter, R., Kapoor, N., Brooks, J., Culver, J., Petucci, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11078-z · Cited by 169
Self-citationRuiz, M., Labarthe, F., Fortier, A., Bouchard, B., Legault, J. T., Bolduc, V., Rigal, O., Chen, J., Ducharme, A., Crawford, P. A., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00820.2016 · Cited by 164
Additional Use of Trimetazidine in Patients With Chronic Heart Failure
Zhang, L., Lu, Y., Jiang, H., Zhang, L., Sun, A., Zou, Y., & Ge, J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.027 · Cited by 163
Impact of Gender on the Myocardial Metabolic Response to Obesity
Peterson, L. R., Soto, P. F., Herrero, P., Mohammed, B. S., Avidan, M. S., Schechtman, K. B., Dence, C., & Gropler, R. J. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.05.004 · Cited by 161
Kappel, B. A., Lehrke, M., Schütt, K. S., Artati, A., Adamski, J., Lebherz, C., & Marx, N. (2017) · Circulation · doi:10.1161/circulationaha.117.029166 · Cited by 157
Nutritional modulation of heart failure in mitochondrial pyruvate carrier–deficient mice
McCommis, K. S., Kovács, A. D., Weinheimer, C. J., Shew, T. M., Koves, T. R., Ilkayeva, O., Kamm, D. R., Pyles, K. D., King, M. T., Veech, R. L., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00296-1 · Cited by 150
Yurista, S. R., Matsuura, T. R., Silljé, H. H. W., Nijholt, K. T., McDaid, K. S., Shewale, S. V., Leone, T. C., Newman, J. C., Verdin, E. M., van Veldhuisen, D. J., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007684 · Cited by 146
Self-citationMitochondrial pyruvate carriers are required for myocardial stress adaptation
Zhang, Y., Taufalele, P., Cochran, J. D., Frayne, I. R., Marx, J. M., Soto, J. E., Rauckhorst, A. J., Tayyari, F., Pewa, A. D., Gray, L. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00288-1 · Cited by 143
Biswas, D., Duffley, L., & Pulinilkunnil, T. (2019) · The FASEB Journal · doi:10.1096/fj.201802842rr · Cited by 132
Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
Fernández-Caggiano, M., Kamynina, A., Francois, A. A., Prysyazhna, O. D., Eykyn, T. R., Krasemann, S., Crespo-Leiro, M. G., Vieites, M. G., Bianchi, K., Morales, V., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00276-5 · Cited by 132
Runte, K. E., Bell, S. P., Selby, D. E., Häußler, T. N., Ashikaga, T., LeWinter, M. M., Palmer, B. M., & Meyer, M. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004311 · Cited by 121
Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy
Flam, E. L., Jang, C., Murashige, D., Yang, Y., Morley, M. P., Jung, S., Kantner, D. S., Pepper, H. L., Bedi, K. C., Brandimarto, J., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00117-6 · Cited by 114
Self-citationExtra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure
Murashige, D., Jung, J. W., Neinast, M. D., Levin, M. G., Chu, Q., Lambert, J. P., Garbincius, J. F., Kim, B., Hoshino, A., Martí-Pàmies, Í., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.008 · Cited by 113
Self-citationTargeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients
Lanfear, D. E., Gibbs, J., Li, J., She, R., Petucci, C. J., Culver, J. A., Tang, W. H. W., Pinto, Y. M., Williams, L. K., Sabbah, H. N., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.07.009 · Cited by 111
Self-citationBranched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart
Walejko, J. M., Christopher, B. A., Crown, S. B., Zhang, G., Pickar‐Oliver, A., Yoneshiro, T., Foster, M. W., Page, S. C., van Vliet, S., Ilkayeva, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21962-2 · Cited by 108
Mahmod, M., Pal, N., Rayner, J. J., Holloway, C. J., Raman, B., Dass, S., Levelt, E., Ariga, R., Ferreira, V. M., Banerjee, R., et al. (2018) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-018-0511-6 · Cited by 97
Kochlik, B., Gerbracht, C., Grune, T., & Weber, D. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201701062 · Cited by 95
Goldenberg, J. R., Carley, A. N., Ji, R., Zhang, X., Fasano, M. J., Schulze, P. C., & Lewandowski, E. D. (2019) · Circulation · doi:10.1161/circulationaha.119.039610 · Cited by 94
Xu, G., Hansen, J. S., Zhao, X., Chen, S., Hoene, M., Wang, X., Clemmesen, J. O., Secher, N. H., Häring, H., Pedersen, B. K., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1859 · Cited by 91
Sheffield‐Moore, M., Dillon, E. L., Randolph, K. M., Casperson, S. L., White, G. R., Jennings, K., Rathmacher, J. A., Schuette, S. A., Janghorbani, M., Urban, R. J., et al. (2013) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-013-0117-7 · Cited by 63
Aslam, M., Hahn, V. S., Jani, V., Hsu, S., Sharma, K., & Kass, D. A. (2020) · Circulation · doi:10.1161/circulationaha.120.052414 · Cited by 60
Self-citationItier, R., Guillaume, M., Ricci, J., Roubille, F., Delarche, N., Picard, F., Galinier, M., & Roncalli, J. G. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13222 · Cited by 56
Harris, L.-A. L. S., Smith, G. I., Patterson, B. W., Ramaswamy, R. S., Okunade, A. L., Kelly, S. C., Porter, L. C., Klein, S., Yoshino, J., & Mittendorfer, B. (2017) · Diabetes · doi:10.2337/db16-1475 · Cited by 52
Ying, W., Sharma, K., Yanek, L. R., Vaidya, D. M., Schär, M., Markl, M., Subramanya, V., Soleimani, S., Ouyang, P., Michos, E. D., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13382 · Cited by 52
Self-citationRazavi, A. C., Bazzano, L., He, J., Fernandez, C., Whelton, S. P., Krousel-Wood, M. A., Li, S., Nierenberg, J. L., Shi, M., Li, C., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015118 · Cited by 49
Kochlik, B., Stuetz, W., Pérès, K., Féart, C., Tegner, J. N., Rodríguez‐Mañas, L., Grune, T., & Weber, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071010 · Cited by 44
Metadata
- Authors
- Hahn, V. S., Petucci, C., Kim, M.-S., Bedi, K. C., Wang, H., Mishra, S., Koleini, N., Yoo, E. J., Margulies, K. B., Arany, Z., Kelly, D. P., Kass, D. A., & Sharma, K.
- Venue
- Circulation
- Published
- 2023-04-11
- Volume
- 147
- Issue
- 15
- Pages
- 1147-1161
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W4322720015
- Cited by
- 294
- References
- 69
- FWCI
- 52.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.